Similar articles

• Tumor vaccines for immunotherapy of canine lymphosarcoma.

  Benjamini E, Theilen GH, Torten M, Fong S, Crow S, Henness AM. Benjamini E, et al. Ann N Y Acad Sci. 1976;277(00):305-12. doi: 10.1111/j.1749-6632.1976.tb41709.x. Ann N Y Acad Sci. 1976. PMID: 793483 Review. No abstract available.
• The transmissible venereal tumor of the dog--a naturally occurring allograft? A review.

  Cohen D. Cohen D. Isr J Med Sci. 1978 Jan;14(1):14-9. Isr J Med Sci. 1978. PMID: 580257 No abstract available.
• B- and T-cells in canine lymphosarcoma.

  Onions DE. Onions DE. Vet Rec. 1975 Aug 9;97(6):108. doi: 10.1136/vr.97.6.108. Vet Rec. 1975. PMID: 1080617 No abstract available.
• T and B lymphocytes in canine lymphosarcoma.

  Koyama H, Kajikawa O, Imamura Y, Ogasawara T, Higuchi S, Yoshikawa H, Yoshikawa T, Saito H. Koyama H, et al. Nihon Juigaku Zasshi. 1985 Feb;47(1):157-60. doi: 10.1292/jvms1939.47.157. Nihon Juigaku Zasshi. 1985. PMID: 3872378 No abstract available.
• [Malignant lymphomas in dogs: a review with reference to non-Hodgkin lymphoma in man].

  Teske E. Teske E. Tijdschr Diergeneeskd. 1994 Dec 1;119(23):705-17. Tijdschr Diergeneeskd. 1994. PMID: 7992303 Review. Dutch. No abstract available.